PAVmed (PAVM) Director Granted 150,000 Restricted Shares

Q: Who filed the Form 4 for PAVmed (PAVM)?

The Form 4 reports transactions by Debra White, who is identified as a director of PAVmed.

Q: What transaction is reported on the Form 4 for PAVM?

A grant of 150,000 restricted shares of common stock was reported with transaction date 09/30/2025 and price $0.

Q: How many shares does the reporting person own after the transaction?

The Form 4 states the reporting person beneficially owns 215,000 shares following the reported transaction.

Q: When do the restricted shares vest and are there conditions?

The restricted stock has a single vesting date of May 20, 2028 and is subject to forfeiture if the requisite service period is not completed.

Q: Who signed the Form 4 and when was it signed?

The Form 4 was signed by Michael A. Gordon, by power of attorney on 10/02/2025.

Debra White, a director of PAVmed Inc. (PAVM), was granted 150,000 shares of restricted common stock on 09/30/2025.

Accepted by SEC EDGAR 10/02/2025 - 04:21 PM EDT

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Debra White, a director of PAVmed Inc. (PAVM), was granted 150,000 shares of restricted common stock on 09/30/2025. The shares were issued at a price of $0 and, after the grant, Ms. White beneficially owns 215,000 shares. The restricted stock vests on May 20, 2028 and is subject to forfeiture if the required service period is not completed.

Positive

150,000 restricted shares were granted to the reporting person
Restricted shares vest on May 20, 2028, a single vesting date

Negative

None.

Insider Trade Summary

Grant/Award: 150,000 shares

Grant/Award 1 txn

Insider White Debra

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common stock	150,000	$0.00	$0.00

Holdings After Transaction: Common stock — 215,000 shares (Direct)

Holdings Before and After: Common stock, 65,000 to 215,000 shares (Direct)

Footnotes (1)

F1. Represents restricted stock granted to the reporting person under the issuer's Sixth Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who filed the Form 4 for PAVmed (PAVM)?

The Form 4 reports transactions by Debra White, who is identified as a director of PAVmed.

What transaction is reported on the Form 4 for PAVM?

A grant of 150,000 restricted shares of common stock was reported with transaction date 09/30/2025 and price $0.

How many shares does the reporting person own after the transaction?

The Form 4 states the reporting person beneficially owns 215,000 shares following the reported transaction.

When do the restricted shares vest and are there conditions?

The restricted stock has a single vesting date of May 20, 2028 and is subject to forfeiture if the requisite service period is not completed.

Who signed the Form 4 and when was it signed?

The Form 4 was signed by Michael A. Gordon, by power of attorney on 10/02/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

White Debra

(Last)

(First)

(Middle)

360 MADISON AVENUE

25TH FLOOR

(Street)

NEW YORK

10017

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
PAVmed Inc. [ PAVM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common stock	09/30/2025		A		150,000⁽¹⁾	A	$0⁽¹⁾	215,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents restricted stock granted to the reporting person under the issuer's Sixth Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed.

	/s/ Michael A. Gordon, by power of attorney	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR